Elite Pharmaceuticals Inc ELTP:OTCQB

RT Quote | Exchange | USD
Last | 2:13 PM EDT
0.0368quote price arrow down-0.0007 (-1.8667%)
Volume
13,030
52 week range
0.02 - 0.06
Loading...
  • Open0.0368
  • Day High0.0368
  • Day Low0.0368
  • Prev Close0.0375
  • 52 Week High0.06
  • 52 Week High Date06/15/21
  • 52 Week Low0.02
  • 52 Week Low Date12/06/21

Key Stats

  • Market Cap37.22M
  • Shares Out1.011B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • YTD % Change11.35

KEY STATS

  • Open0.0368
  • Day High0.0368
  • Day Low0.0368
  • Prev Close0.0375
  • 52 Week High0.06
  • 52 Week High Date06/15/21
  • 52 Week Low0.02
  • 52 Week Low Date12/06/21
  • Market Cap37.22M
  • Shares Out1.011B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • YTD % Change11.35

RATIOS/PROFITABILITY

  • EPS (TTM)0.00
  • P/E (TTM)10.34
  • Fwd P/E (NTM)-
  • EBITDA (TTM)4.383M
  • ROE (TTM)30.37%
  • Revenue (TTM)28.99M
  • Gross Margin (TTM)45.56%
  • Net Margin (TTM)17.70%
  • Debt To Equity (MRQ)8.05%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Elite Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Elite Pharmaceuticals, Inc. (Elite), is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets (either on its own or by license to other companies) generic controlled-release and abuse deterrent...
Nasrat Hakim
Chairman of the Board, President, Chief Executive Officer
Douglas Plassche
Executive Vice President - Operations
Jason LePree Ph.D.
Vice President - Scientific and Medical Affairs
Address
165 Ludlow Ave
Northvale, NJ
07647-2305
United States

Top Peers

SYMBOLLASTCHG%CHG
ACRX
AcelRx Pharmaceuticals Inc
0.2581+0.0031+1.22%
ZYNE
Zynerba Pharmaceuticals Inc
1.00+0.04+4.28%
TRVN
Trevena Inc
0.2439-0.0222-8.3427%
AVTX
Avalo Therapeutics Inc
0.3201-0.0048-1.4774%
NAVB
Navidea Biopharmaceuticals Inc
0.8173+0.0019+0.23%
ACUR
Acura Pharmaceuticals Inc
0.348UNCHUNCH